Gilead Sciences Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
99 result(s) found, displaying 61 to 70
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ODEFSEY emtricitabine (200 mg), rilpivirine (25 mg), tenofovir alafenamide (25 mg) fixed-dose combination tablet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DESCOVY 200 mg/25 mg ( 200 mg emtricitabine/25 mg tenofovir alafenamide) tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DESCOVY 200 mg/10 mg (200 mg emtricitabine/10 mg tenofovir alafenamide) tablet bottle.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (as fumarate)
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GENVOYA elvitegravir (150mg), cobicistat (150mg), emtricitabine (200mg) and tenofovir alafenamide (as fumarate) (10mg) fixed dose combination tablets.
-
Prescription medicine registrationActive ingredients: bictegravir (as sodium); tenofovir alafenamide (as fumarate); emtricitabine.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HARVONI ledipasvir/sofosbuvir 90 mg/400 mg tablet bottle.
-
Prescription medicine registrationActive ingredients: tenofovir alafenamide fumarate; emtricitabine; elvitegravir; cobicistat.
-
Prescription medicine registrationActive ingredients: sofosbuvir/velpatasvir/voxilaprevir.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ZYDELIG idelalisib 100 mg tablet bottle.